![Jianyuan Luo](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jianyuan Luo
Directeur/Bestuurslid bij Continent Pharmaceutical Inc.
Actieve functies van Jianyuan Luo
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Continent Pharmaceutical Inc.
![]() Continent Pharmaceutical Inc. Pharmaceuticals: MajorHealth Technology Continent Pharmaceutical Inc. operates as orphan drug company. It develops, manufactures and distributes pharmaceutical products for the treatment of organ fibrosis and other orphan diseases. Its products includes ETUARY and generic drugs. The company was founded on July 3, 2002 and is headquartered in Beijing, China. | Directeur/Bestuurslid | 01-01-2019 | - |
Independent Dir/Board Member | 01-01-2019 | - | |
The Chinese Medical Association | Corporate Officer/Principal | 01-02-2013 | - |
Beijing Continent Pharmaceutical Co., Ltd.
![]() Beijing Continent Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Continent Pharmaceutical Co. Ltd. is a commercial-stage biopharmaceutical company committed to the research, development and commercialization of innovative drugs for organ fibrosis for two decades. The firm focuses on idiopathic pulmonary fibrosis (“IPF”) and have gradually broadened therapeutic field and research & development efforts to other areas of organ fibrosis. The company flagship product ETUARY (pirfenidone capsule) was approved in China in 2011 and is among the first three approved drugs for IPF worldwide. The firm has developed a pipeline of additional four innovative drug candidates, and amassed eight-years’ experience of successful commercialization. The company was founded in July 2002 and is headquartered in Beijing, China. | Directeur/Bestuurslid | - | - |
Independent Dir/Board Member | - | - |
Loopbaan van Jianyuan Luo
Eerdere bekende functies van Jianyuan Luo
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
University of Maryland | Corporate Officer/Principal | 01-05-2010 | 01-01-2015 |
Opleiding van Jianyuan Luo
Peking University | Undergraduate Degree |
University of Kentucky | Doctorate Degree |
Statistieken
Internationaal
China | 5 |
Verenigde Staten | 3 |
Operationeel
Director/Board Member | 2 |
Independent Dir/Board Member | 2 |
Corporate Officer/Principal | 2 |
Sectoraal
Consumer Services | 4 |
Health Technology | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 3 |
---|---|
Continent Pharmaceutical Inc.
![]() Continent Pharmaceutical Inc. Pharmaceuticals: MajorHealth Technology Continent Pharmaceutical Inc. operates as orphan drug company. It develops, manufactures and distributes pharmaceutical products for the treatment of organ fibrosis and other orphan diseases. Its products includes ETUARY and generic drugs. The company was founded on July 3, 2002 and is headquartered in Beijing, China. | Health Technology |
The Chinese Medical Association | |
Beijing Continent Pharmaceutical Co., Ltd.
![]() Beijing Continent Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Continent Pharmaceutical Co. Ltd. is a commercial-stage biopharmaceutical company committed to the research, development and commercialization of innovative drugs for organ fibrosis for two decades. The firm focuses on idiopathic pulmonary fibrosis (“IPF”) and have gradually broadened therapeutic field and research & development efforts to other areas of organ fibrosis. The company flagship product ETUARY (pirfenidone capsule) was approved in China in 2011 and is among the first three approved drugs for IPF worldwide. The firm has developed a pipeline of additional four innovative drug candidates, and amassed eight-years’ experience of successful commercialization. The company was founded in July 2002 and is headquartered in Beijing, China. | Health Technology |
- Beurs
- Insiders
- Jianyuan Luo
- Ervaring